PM360 2018 Innovative Product Access Express from Health Strategies Group, an EVERSANA company

Access Express

Health Strategies Group, an EVERSANA company

Rod Cavin, General Manager
info@healthstrategies.com 

Sometimes you need answers—fast. But fast shouldn’t mean you need to compromise on quality. Access Express is a self-service custom research tool for biopharmaceutical market researchers that leverages Health Strategies Group’s robust panel of providers and payers to provide answers to your questions in one week’s time.

Simply log on to an easy-to-use portal, select your target respondent roles, set your sample size preferences, and submit 5-10 questions. The entire research process—including survey programming—will be managed by Health Strategies Group’s experienced in-house research team. And the results will be available in six business days.

Access Express can provide quick, credible answers to time-sensitive questions, including the ability to:

  • Gather information you need for planning.
  • Answer questions from senior management.
  • Gain quick market reactions.
  • Monitor the effectiveness of your programs and tactics.
  • Assess the real-time impact of changes in formulary and contracts.

Access Express reduces the time for projects from 13 weeks to one week, creating a quick and cost-effective alternative for clients. Health Strategies Group recently completed 50 projects across a broad spectrum of needs, including business development, message testing, copay receptivity, and drug packaging receptivity.

Ads

You May Also Like

PM360 2020 Innovative Division Chiesi Global Rare Diseases Business Unit of Chiesi Farmaceutici S.p.A.

Chiesi Global Rare Diseases Business Unit Chiesi Farmaceutici S.p.A. Giacomo Chiesi, Head of Global ...

Healthcare Watch October 2018

Therapeutic Talk: Medical Breakthrough Helps Paralyzed Patients Walk The latest and most dramatic advancement ...

2020 Pharma Choice Professional Print Campaign Silver Winner Elevate Healthcare and Recordati Rare Diseases

Elevate Healthcare and Recordati Rare Diseases Help Settle the Storm Cushing’s disease patients endure ...